NationalResearchCorp . (NYSE:NRC) shares hit a new 52-week high on Friday . The stock traded as high as $58.66 and last traded at $56.47, with a volume of 2480 shares trading hands. The stock had previously closed at $55.28.
Separately, William Blair reiterated a “market perform” rating on shares of NationalResearchCorp . in a report on Tuesday, March 19th.
The stock’s fifty day simple moving average is $51.30.
The firm also recently declared a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Friday, June 28th will be issued a $0.19 dividend. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $0.76 annualized dividend and a yield of 1.32%.
In other NationalResearchCorp . news, major shareholder K/I/E Trust Under Agreement 10 sold 1,106 shares of the business’s stock in a transaction on Thursday, April 11th. The stock was sold at an average price of $40.00, for a total value of $44,240.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold a total of 91,881 shares of company stock valued at $3,675,854 over the last quarter.
Several hedge funds and other institutional investors have recently made changes to their positions in NRC. Advisor Group Inc. grew its stake in shares of NationalResearchCorp . by 17.9% during the 4th quarter. Advisor Group Inc. now owns 1,860 shares of the company’s stock valued at $72,000 after buying an additional 282 shares during the period. Legal & General Group Plc grew its stake in shares of NationalResearchCorp . by 35.0% during the 4th quarter. Legal & General Group Plc now owns 2,118 shares of the company’s stock valued at $81,000 after buying an additional 549 shares during the period. BNP Paribas Arbitrage SA grew its stake in shares of NationalResearchCorp . by 10,395.5% during the 1st quarter. BNP Paribas Arbitrage SA now owns 2,309 shares of the company’s stock valued at $89,000 after buying an additional 2,287 shares during the period. Citigroup Inc. grew its stake in shares of NationalResearchCorp . by 17.1% during the 4th quarter. Citigroup Inc. now owns 3,342 shares of the company’s stock valued at $127,000 after buying an additional 489 shares during the period. Finally, Metropolitan Life Insurance Co. NY grew its stake in shares of NationalResearchCorp . by 354.8% during the 4th quarter. Metropolitan Life Insurance Co. NY now owns 3,511 shares of the company’s stock valued at $134,000 after buying an additional 2,739 shares during the period.
About NationalResearchCorp . (NYSE:NRC)
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provide actionable information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience, satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement.
Further Reading: Technical Indicators – What is a Golden Cross?
Receive News & Ratings for NationalResearchCorp . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NationalResearchCorp . and related companies with MarketBeat.com's FREE daily email newsletter.